Margaret Hamburg

From Wikipedia, the free encyclopedia
(Redirected from Margaret A. Hamburg)
Peggy Hamburg
Hamburg in 2015
21st Commissioner of Food and Drugs
In office
May 22, 2009 – April 3, 2015
PresidentBarack Obama
Preceded byAndrew von Eschenbach
Succeeded byRobert Califf
Assistant Secretary of Health and Human Services for Planning and Evaluation
In office
1997–2001
PresidentBill Clinton
Preceded byPeter Edelman[1]
Succeeded byBobby Jindal[2]
Health Commissioner of New York City
In office
December 24, 1991 – April 15, 1997
Acting: June 11, 1991 – December 24, 1991
MayorDavid Dinkins
Rudy Giuliani
Preceded byWoody Myers
Succeeded byBenjamin Mojica
Personal details
Born (1955-07-12) July 12, 1955 (age 68)
Chicago, Illinois, U.S.
Political partyDemocratic
Spouse
​
(m. 1992)​
RelativesBeatrix Hamburg (Mother)
David A. Hamburg (Father)
EducationHarvard University (BA, MD)

Margaret Ann "Peggy" Hamburg (born July 12, 1955, Chicago, Illinois) is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS)[3] and co-chair of the InterAcademy Partnership (IAP).[4] She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.[5]

Early life and education[edit]

Hamburg is the daughter of Beatrix Hamburg and David A. Hamburg, both physicians. Her mother was the first self-identified African-American woman to be accepted at Vassar College[6] and to earn a degree from the Yale University School of Medicine.[7] Her father is President Emeritus of the Carnegie Corporation of New York and also served as the president of the AAAS in 1984.[8][9]

Hamburg graduated from Harvard College in 1977 and earned her M.D. from Harvard Medical School in 1983.[10] She completed her medical residency training at the New York Hospital-Cornell Medical Center and is Board Certified in Internal Medicine.

Hamburg is married to Peter Fitzhugh Brown, a computer scientist and artificial intelligence expert. The couple were married on May 23, 1992.[11] Brown is the chief executive officer of Renaissance Technologies.[12] Renaissance Technologies employees were collectively the top donors to President Donald Trump's 2016 campaign[13] and collectively the third largest donors to Hillary Clinton,[14] giving $15.5 million and $16.5 million respectively. The couple has two children together.

Hamburg was ranked on the list of The World's 100 Most Powerful Women three times—ranking 21st in 2011, 61st in 2012, and 59th in 2013.[15]

Career[edit]

Following her medical training, Hamburg moved to Washington, D.C., to begin her career in public service. She served in several roles, beginning with a position in the Office of Disease Prevention and Health Promotion at the US Department of Health and Human Services.[16] She also worked as a clinical instructor for Georgetown University School of Medicine from 1986 to 1990.[17]

From May 1989 to May 1990, she worked as Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health under Anthony Fauci. In this position, she participated in HIV/AIDS policy development and research.[18]

In 1991 Hamburg was appointed Commissioner of the New York City Department of Health and Mental Hygiene, where she served for six years, working first for Mayor David Dinkins and then-Mayor Rudy Giuliani. During her tenure, she worked on improved services for women and children, a needle-exchange program to reduce HIV transmission, a program to curtail the resurgence and spread of tuberculosis, and the nation's first public health bioterrorism preparedness program.[19]

In 1997, President Bill Clinton appointed Hamburg as Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services. She served in this policy role until 2001 when she became the founding Vice President for Biological Programs and later the Senior Scientist for the Nuclear Threat Initiative,[20] a foundation created by Ted Turner dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that role, Hamburg spearheaded efforts to prevent, detect, and respond to both naturally occurring and deliberately caused biological threats. She worked on reforms to reduce the dangers associated with modern bioterrorism and infectious diseases such as pandemic influenza.

In June 2001, Hamburg participated in the Operation Dark Winter exercise at Andrews Air Force Base simulating a bioterrorism event involving weaponized smallpox.[21]

Hamburg is a member of the Medical Advisory Team for the Sidwell Friends School, where she also served on the board of trustees from 2004 to 2009.[22] On July 13, 2005, she was announced as an advisor to the Project on Emerging Nanotechnologies by the Pew Charitable Trusts and Woodrow Wilson International Center for Scholars.[23]

U.S. Food and Drug Administration[edit]

Hamburg (center right) visits a California rice farm in 2013 while Commissioner of the FDA

Hamburg was nominated by President Barack Obama in March 2009 to become Commissioner of the Food and Drug Administration,[24] and was unanimously confirmed in May 2009.[25] As FDA Commissioner she was known for advancing regulatory science, streamlining and modernizing FDA's regulatory pathways, and globalization of the agency, as well as the implementation of the Family Smoking Prevention and Tobacco Control Act (2009), the Food Safety Modernization Act (2011), and a review of the system for the evaluation and approval of medical devices.

Hamburg was the longest-serving FDA commissioner since David A. Kessler, as well as the second woman to hold the position.[26] She served at the FDA until her resignation on March 28, 2015.[27][28][29][30]

During Hamburg's tenure at the FDA, the agency was criticized for speeding approvals at the expense of safety, while some industry voices indicated the pace was "justified". The FDA, under Hamburg's leadership approved 51 drugs in 2014 alone, which was noted as being "most in more than 20 years" to which Hamburg attributes to "innovative approaches".[29]

National Academy of Medicine[edit]

In April 2015 Hamburg was appointed Foreign Secretary of the National Academy of Medicine.[31] In December 2016, Hamburg was named president-elect for the American Association for the Advancement of Science.[32] She served a three-year term as an officer and member of the Executive Committee of the AAAS Board of Directors beginning in February 2017.

In 2018, she participated in the Clade X pandemic exercise that modelled a fictional parainfluenza bioterrorism attack designed to reduce the global population.[33][34] She played the role of Secretary of Health and Human Services.[35] The event was held by the Johns Hopkins Center for Health Security.[36] Hamburg joined the board of directors for Alnylam Pharmaceuticals in 2018.[37]

In 2020, Hamburg participated in the strategic framework development for the Grand Challenge on Climate Change, Human Health, & Equity. Other notable participants included Peter Daszak of EcoHealth Alliance, Jeremy Farrar of Wellcome Trust, and representatives from the National Institutes of Health, Rockefeller Foundation, London School of Hygiene & Tropical Medicine, ExxonMobil, University of Hong Kong, Burroughs Wellcome Fund, World Health Organization, African Development Bank, Robert Wood Johnson Foundation, National Oceanic and Atmospheric Administration, and numerous universities.[38]

Additionally, Hamburg was appointed by the Council on Foreign Relations to serve on its Independent Task Force on Improving Pandemic Preparedness, co-chaired by Sylvia Mathews Burwell and Frances Fragos Townsend.[39] That year, she also served on the CSIS-LSHTM High-Level Panel[40] on Vaccine Confidence and Misinformation amid the COVID-19 pandemic, co-chaired by Heidi Larson and J. Stephen Morrison.[41]

Hamburg participated in a tabletop exercise at the March 2021 Munich Security Conference modelling a fictional international outbreak of monkeypox.[42] The exercise was led by the Nuclear Threat Initiative and funded by Open Philanthropy.[43] In the exercise scenario, the hypothetical outbreak was set to begin on May 15, 2022. On May 18, 2022, a real confirmed case of monkeypox was reported in an American traveller who had recently travelled to Canada.[44]

See also: 2022 monkeypox outbreak

Awards and recognition[edit]

Margaret A. Hamburg at Spotlight Health, Aspen Ideas Festival, in 2015.

Hamburg is a Fellow of the American Association for the Advancement of Science and the American College of Physicians, as well as a member of the Council on Foreign Relations and the National Academy of Medicine, where she now serves as Foreign Secretary.

Hamburg has received numerous awards, among them the National Consumers League's Trumpeter Award in 2011[45] and the National Center for Health Research's 2011 Health Research Policy Hero Award.[46] She has also received the American College of Clinical Pharmacology's (ACCP) Nathaniel T. Kwit Memorial Distinguished Service Award,[47] the New York Academy of Medicine Medal for Distinguished Contributions in Health Policy,[48] the Radcliffe Alumnae Award and the American Lung Association's Breath of Life Award. Hamburg was the 2017 recipient of the FDAAA's Harvey W. Wiley Lecture Award for Outstanding Leadership in Advancing Public Health.

She is a distinguished senior fellow with the Center for Strategic and International Studies[49] and holds several Honorary Degrees.

Forbes named her as one of the world's 100 most powerful women multiple times, most recently in 2014 (#51).[50]

In 2022, Hamburg was awarded the AAAS Philip Hauge Abelson Prize which honors individuals' groundbreaking work in the areas of public service, scientific achievement or notable services to community.[26]

Other activities[edit]

Corporate boards[edit]

Non-profit organizations[edit]

Hamburg formerly served on the boards of the Rockefeller Foundation, the Rockefeller University, the Nathan Cummings Foundation, Conservation International and Henry Schein Inc. She has participated as a member of the Central Intelligence Agency's Intelligence Science Board.[70]

She is also a member of the National Advisory Council for the COVID Collaborative.[71]

Hamburg is affiliated with the World Economic Forum.[72] On April 6, 2021, she participated as a speaker at a WEF event titled "The Next Frontier: Synthetic Biology".[73]

Legal issues[edit]

In 2016, Hamburg, her husband, Johnson & Johnson, and others were named in a lawsuit by Larry Klayman, who has since been suspended from practicing law in DC. The suit was dismissed with prejudice in 2017 by a District of Columbia federal judge.[74]

Selected publications[edit]

References[edit]

  1. ^ "PN530 - Nomination of Margaret Ann Hamburg for Department of Health and Human Services, 105th Congress (1997-1998)". www.congress.gov. 30 October 1997.
  2. ^ "PN249 - Nomination of Piyush Jindal for Department of Health and Human Services, 107th Congress (2001-2002)". www.congress.gov. 25 May 2001.
  3. ^ "Organization and Governance". American Association for the Advancement of Science. Retrieved 2019-04-16.
  4. ^ Partnership (IAP), the InterAcademy (17 April 2019). "World's science academies gather in Korea to elect new chairs, welcome new members, and stand up for sustainable development". www.interacademies.org. Retrieved 2022-04-21.
  5. ^ FDA head Margaret Hamburg to resign in March; Ostroff to be acting chief (Washington Post article-February 5, 2015)
  6. ^ Streett, Laura (February 11, 2014). "Vassar's First Black Students". The Gargoyle Bulletin. Vassar College. Retrieved April 23, 2016.
  7. ^ Peart, Karen N. (May 27, 2011). "School of Medicine honors its first African-American women graduates". Yale News. Yale University. Retrieved April 23, 2016.
  8. ^ "New AAAS President Emphasizes Science as Public Service". AAAS. 2018-02-22. Retrieved 2018-09-05.
  9. ^ Lederberg, Joshua (1983-07-29). "David A. Hamburg: President-Elect of AAAS". Science. 221 (4609): 431–432. Bibcode:1983Sci...221..431L. doi:10.1126/science.221.4609.431. ISSN 0036-8075. PMID 17755464.
  10. ^ "Margaret Hamburg | University of Washington - Department of Global Health". globalhealth.washington.edu. Retrieved 2022-04-04.
  11. ^ "AllGov - Officials". www.allgov.com. Retrieved 2022-04-04.
  12. ^ Patterson, Scott; Strasburg, Jenny (16 March 2010). "Pioneering Fund Stages Second Act". Wall Street Journal. Retrieved 19 December 2017.
  13. ^ "Top Contributors, federal election data for Donald Trump, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
  14. ^ "Top Contributors, federal election data for Hillary Clinton, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
  15. ^ "Margaret a Hamburg, American Association for the Advancement of Science: Profile and Biography". www.bloomberg.com. Retrieved 2022-04-04.
  16. ^ "Changing the Face of Medicine | Dr. Margaret Hamburg". National Library of Medicine. Archived from the original on 2009-03-25. Retrieved 2022-07-18.{{cite web}}: CS1 maint: unfit URL (link)
  17. ^ Wallechinsky, David (2016). "Hamburg, Margaret". AllGov - Officials. Archived from the original on 2022-07-18. Retrieved 2022-07-18.
  18. ^ "Margaret Hamburg". Broad Institute. 2021-06-07. Archived from the original on 2022-05-27. Retrieved 2022-07-18.
  19. ^ "Biography of Margaret A. Hamburg, M.D." U.S. Food & Drug Administration.
  20. ^ Pugh, Tony (5 February 2015). "FDA commissioner Margaret Hamburg to step down in March". McClatchy DC. McClatchy Washington Bureau. Retrieved 19 September 2016.
  21. ^ "Dark Winter". Johns Hopkins Center for Health Security. Archived from the original on 2022-05-28. Retrieved 2022-05-28.
  22. ^ "Medical Advisory Team". Sidwell Friends. Archived from the original on 2022-06-02. Retrieved 2022-07-18.
  23. ^ "Pew Charitable Trusts, Wilson Center Launch Project on Emerging Nanotechnologies". Project on Emerging Nanotechnologies. 2005-07-13. Archived from the original on 2022-07-18. Retrieved 2022-07-18.
  24. ^ Gardiner Harris (11 March 2009). "Ex-New York Health Commissioner Is F.D.A. Pick". The New York Times. Retrieved 2009-03-12.
  25. ^ Gratzer, David (2009-05-21). "FDA commissioner". US FDA. Retrieved 2010-09-12.
  26. ^ a b "Margaret A. Hamburg Wins 2022 AAAS Abelson Prize | American Association for the Advancement of Science". www.aaas.org. Retrieved 2022-04-04.
  27. ^ Dennis, Brady (2015-02-05). "FDA head Margaret Hamburg to resign in March". Washington Post. ISSN 0190-8286. Retrieved 2022-04-04.
  28. ^ "FDA Commissioner Margaret Hamburg To Resign in March, Writes Farewell Letter to FDA Colleagues". Policy & Medicine. Retrieved 2022-04-04.
  29. ^ a b Tavernise, Sabrina (2015-02-05). "F.D.A. Commissioner Leaving After Six Years of Breakneck Changes". The New York Times. ISSN 0362-4331. Retrieved 2022-04-04.
  30. ^ "Biography of Margaret A. Hamburg, M.D." U.S. Food & Drug Administration.
  31. ^ "Margaret A. Hamburg Appointed as Institute of Medicine Foreign Secretary". nationalacademies.org. The National Academies of Sciences, Engineering, and Medicine. April 6, 2015. Retrieved April 23, 2016.
  32. ^ Korte, Andrea. "Margaret Hamburg Selected to Serve as AAAS President-Elect". AAAS. Retrieved 9 January 2017.
  33. ^ Alexopulos, Nick (2018-05-15). "Clade X policy recommendations". Johns Hopkins Center for Health Security. Archived from the original on 2021-04-14. Retrieved 2022-05-28.
  34. ^ "Clade X Slides" (PDF). Johns Hopkins Center for Health Security. 2018. Archived (PDF) from the original on 2022-01-13. Retrieved 2022-05-28.
  35. ^ Cizek, Julia. "Bio of Margaret Hamburg, playing the role of Sec. of HHS | Clade X". Johns Hopkins Center for Health Security. Archived from the original on 2022-05-31. Retrieved 2022-05-31.
  36. ^ Watson, Crystal; Toner, Eric S.; Shearer, Matthew P.; Rivers, Caitlin; Meyer, Diane; Hurtado, Christopher; Watson, Matthew; Gronvall, Gigi Kwik; Adalja, Amesh A.; Sell, Tara Kirk; Inglesby, Tom (2019-10-01). "Clade X: A Pandemic Exercise". Health Security. 17 (5): 410–417. doi:10.1089/hs.2019.0097. ISSN 2326-5094. PMID 31593508. S2CID 203984655.
  37. ^ "The Alnylam® Leadership Team". Alnylam Pharmaceuticals. Archived from the original on 2022-05-27. Retrieved 2022-07-18.
  38. ^ "Climate Change Planning Committee". National Academy of Medicine. Archived from the original on 2022-05-29. Retrieved 2022-05-29.
  39. ^ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.
  40. ^ "Former FDA commissioner Margaret Hamburg named in massive conspiracy and racketeering lawsuit involving Johnson & Johnson, a Wall Street hedge fund, and the Levaquin drug – Crescent City Times.com". Retrieved 2022-04-04.
  41. ^ Call to Action: CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation, October 19, 2020 Center for Strategic and International Studies (CSIS).
  42. ^ "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats". Nuclear Threat Initiative. Archived from the original on 2022-05-26. Retrieved 2022-05-28.
  43. ^ "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats" (PDF). Nuclear Threat Initiative. November 2021. Archived (PDF) from the original on 2022-05-27. Retrieved 2022-05-28.
  44. ^ Reilly, Patrick (2022-05-18). "First case of monkeypox confirmed in US this year in man who had traveled to Canada". New York Post. Archived from the original on 2022-05-19. Retrieved 2022-05-28.
  45. ^ "2011 Trumpeter Recipient: Dr. Margaret Hamburg". 4 October 2011. Retrieved 11 March 2015.
  46. ^ "2011 Foremothers & Health Policy Hero Awards". National Research Center for Women & Families. Archived from the original on 14 May 2011. Retrieved 19 November 2012.
  47. ^ "2016 ACCP Annual Meeting". American College of Clinical Pharmacology.
  48. ^ "The Academy Medal for Distinguished Contributions in Health Policy". The New York Academy of Medicine.
  49. ^ Office of Research on Women's Health (25 March 2004). "Dr. Margaret Hamburg". Changing the Face of Medicine. National Institutes of Health. Retrieved 2009-03-06.
  50. ^ "The World's 100 Most Powerful Women". Forbes. Retrieved 26 June 2014.
  51. ^ Leadership Alnylam Pharmaceuticals.
  52. ^ "Board of Trustees". American Museum of Natural History. Retrieved 19 September 2016.
  53. ^ "Leadership". amfAR, The Foundation for AIDS Research. 2008. Archived from the original on 2008-04-16. Retrieved 2022-07-18.
  54. ^ "Scientific Advisory Committee". Bill & Melinda Gates Foundation. Retrieved 19 September 2016.
  55. ^ "Dr. Margaret A. Hamburg". Bipartisan Commission on Biodefense. Archived from the original on 2022-05-29. Retrieved 2022-07-18.
  56. ^ "Board of Directors". Broad Institute. 2021. Archived from the original on 2021-11-01. Retrieved 2022-07-18.
  57. ^ CSIS Announces Commission on Strengthening America’s Health Security Center for Strategic and International Studies (CSIS), press release of October 2, 2017.
  58. ^ Members of the Commission on Strengthening America’s Health Security Center for Strategic and International Studies (CSIS).
  59. ^ "CEPI Developments". GloPID-R. Archived from the original on 2022-05-27. Retrieved 2022-05-27.
  60. ^ CEPI Board membership updates Coalition for Epidemic Preparedness Innovations (CEPI), press release of 5 April 2023.
  61. ^ "Margaret A. Hamburg, M.D., Elected to Commonwealth Fund Board of Directors". The Commonwealth Fund. 31 July 2015.
  62. ^ "CoRE Advisory Board". Duke-NUS Medical School. Archived from the original on 2022-05-28. Retrieved 2022-05-28.
  63. ^ External Advisory Board: Margaret Hamburg Department of Global Health, University of Washington.
  64. ^ Board members GAVI Alliance
  65. ^ "Harvard Medical School Board of Fellows". Harvard Medical School. Retrieved 19 September 2016.
  66. ^ Board of Directors Nuclear Threat Initiative (NTI).
  67. ^ Scientific Advisory Board for the Autism Research Initiative: Margaret Hamburg Simons Foundation.
  68. ^ "Board of Trustees". Urban Institute. 2017-10-25. Archived from the original on 2016-09-25. Retrieved 2016-09-19.
  69. ^ "Vaccines and Drug-resistant Infections Strategic Advisory Board". Wellcome Trust. Archived from the original on 2020-09-30. Retrieved 2022-05-28.
  70. ^ "Countering the Threat of Radiological Weapons". Center for American Progress. 2005-07-27. Archived from the original on 2022-06-01. Retrieved 2022-06-02.
  71. ^ "About". COVID Collaborative. Archived from the original on 2022-05-15. Retrieved 2022-06-01.
  72. ^ "Margaret A. Hamburg". World Economic Forum. Archived from the original on 2022-05-22. Retrieved 2022-05-28.
  73. ^ "The Next Frontier: Synthetic Biology". World Economic Forum. 2021-04-06. Archived from the original on 2021-04-28. Retrieved 2022-05-28.
  74. ^ "Levaquin RICO Lawsuit Dismissed By Judge In District Of Columbia - Lexis Legal News". www.lexislegalnews.com. Retrieved 2022-04-04.

External links[edit]

Wikimedia Commons has media related to Margaret A. Hamburg.
Government offices
Preceded by Health Commissioner of New York City
1991–1997 		Succeeded by
Benjamin Mojica
Preceded by Assistant Secretary of Health and Human Services for Planning and Evaluation
1997–2001 		Succeeded by
Preceded by Commissioner of Food and Drugs
2009–2015 		Succeeded by
Retrieved from "https://en.wikipedia.org/w/index.php?title=Margaret_Hamburg&oldid=1217145586"